lisuride has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilera-Rodríguez, R; Álvarez Sánchez, M; Álvarez-González, L; Canales-Ochoa, N; Estupiñán-Rodríguez, A; Galicia Polo, L; Haro-Valencia, R; Medrano-Montero, J; Peña-Acosta, A; Rodríguez Pupo, N; Rodríguez-Labrada, R; Vázquez-Mojena, Y; Velázquez-Pérez, L | 1 |
1 other study(ies) available for lisuride and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
Lisuride reduces involuntary periodic leg movements in spinocerebellar ataxia type 2 patients.
Topics: Adult; Dopamine Agonists; Female; Humans; Leg; Lisuride; Male; Middle Aged; Polysomnography; Restless Legs Syndrome; Sleep; Spinocerebellar Ataxias | 2012 |